ACETYLCYSTEINUM

Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii

Published: Aug 6, 2026

Updated: Aug 6, 2026

Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Poland, Europe, this opportunity is open to firms and consortiums. Proposals must be submitted before August 21, 2026.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

This tender, sourced from Poland via TED, is for the supply of 'ACETYLCYSTEINUM' in the form of effervescent tablets, specifically 200mg per tablet, with each package containing 20 tablets. The contracting authority is seeking a pharmaceutical supplier for this medication. Acetylcysteine is commonly used as a mucolytic agent, helping to break down and thin mucus in the airways, and is also used as an antidote for paracetamol overdose. The tender will likely specify requirements related to the quality and pharmaceutical grade of the product, packaging standards, shelf life, and delivery logistics. Bidders are expected to provide documentation demonstrating compliance with relevant pharmaceutical manufacturing standards (e.g., GMP - Good Manufacturing Practice) and regulatory approvals. The tender documentation will detail the quantities required, delivery schedules, and specific quality control measures. This procurement is essential for ensuring the availability of this medication for healthcare purposes within Poland.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on August 6, 2026. Last refreshed today. Original language: Polish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii

Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii has issued 66 procurement notices on BidsFactory, including 10 currently open and 21 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Poland. Notices are distributed via TED - Tenders Electronic Daily (EU) and Poland e-Zamówienia. Most recent publication: August 6, 2026.

Frequently asked questions about this tender

Who is the contracting authority?

This notice was issued by Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is August 21, 2026. You have 15 days left to prepare and submit your proposal to the contracting authority.